HYBRID EVENT: You can participate in person at Madrid, Spain or Virtually from your home or work.

9th Edition of International Conference on Dentistry
and Oral Health

September 02-04, 2024 | Madrid, Spain

September 02-04, 2024 | Madrid, Spain
ICDO 2024

Adekorede Joan Achraf Adechoubou

Adekorede Joan Achraf Adechoubou, Speaker at Dental Conferences
Temple University Kornberg School of Dentistry, United States
Title: The use of botox as a treatment modality for temporomandibular disorders


Temporomandibular Joint Disorders (TMD) encompass a spectrum of conditions affecting the temporomandibular joint and associated masticatory muscles, manifesting diversely among individuals. These disorders are pervasive, impacting a substantial portion of the adult population, with prevalence rates reaching up to 20%. Treatment approaches for TMD vary widely, ranging from conservative measures suitable for mild cases to surgical interventions reserved for severe presentations. However, the pursuit of novel therapeutic avenues remains paramount in TMD management.

One such innovative approach gaining momentum is the utilization of botulinum toxin (Botox). Derived from the bacterium Clostridium botulinum, Botox acts by inhibiting the release of acetylcholine at neuromuscular junctions, thereby inducing muscle relaxation. This mechanism makes it a promising candidate for alleviating the muscle hyperactivity and associated pain characteristic of TMD.

This discourse delves into the emerging role of Botox as a progressive treatment modality for TMD, shedding light on recent research findings and the rationale underpinning its adoption. Offering a moderately invasive alternative, Botox holds promise in enhancing the quality of life for afflicted individuals. By exploring the evolving landscape of Botox utilization in TMD management, this presentation underscores its potential to redefine the treatment paradigm for this prevalent and often debilitating condition.

In essence, this discussion underscores the transformative potential of Botox in mitigating the burdens associated with TMD, advocating for its integration into the therapeutic armamentarium to address the multifaceted challenges posed by this widespread ailment.

Audience Take Away: 

  • Learn more about temporomandibular disorders.
  • Learn about the current treatment modalities for temporomandibular disorders.
  • Learn about Botox and why it can be used to treat temporomandibular disorders.


Dr. Joan Adechoubou studied Biology at Virginia Commonwealth University, and graduated as BS in 2020 with a minor in Chemistry and Business. He then moved to Temple University Kornberg School of Dentistry, where he is currently in his final year, and will receive his DMD in 2024. Throughout his time at Temple University’s school of dentistry, he has developed an interest for the field of Oral and Maxillofacial Surgery and will complete a one year postdoctoral internship at the Virginia Commonwealth University’s department of Oral and Maxillofacial Surgery.